Preclinical Studies of 68Ga-DOTATOC: Biodistribution Assessment in Syrian Rats and Evaluation of Absorbed Dose in Human Organs

Objective(s): Gallium-68 DOTA-DPhe1-Tyr3-Octreotide (68Ga-DOTATOC) has been applied by several European centers for the treatment of a variety of human malignancies. Nevertheless, definitive dosimetric data are yet unavailable. According to the Society of Nuclear Medicine and Molecular Imaging, rese...

Full description

Bibliographic Details
Main Authors: mojdeh naderi, samaneh zolghadri, hassan yousefnia, ali ramazani, amir reza jalilian
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2016-01-01
Series:Asia Oceania Journal of Nuclear Medicine and Biology
Subjects:
Online Access:http://aojnmb.mums.ac.ir/pdf_5043_76a2ad14878b96963330ff68c4e18f99.html
_version_ 1818528715441700864
author mojdeh naderi
samaneh zolghadri
hassan yousefnia
ali ramazani
amir reza jalilian
author_facet mojdeh naderi
samaneh zolghadri
hassan yousefnia
ali ramazani
amir reza jalilian
author_sort mojdeh naderi
collection DOAJ
description Objective(s): Gallium-68 DOTA-DPhe1-Tyr3-Octreotide (68Ga-DOTATOC) has been applied by several European centers for the treatment of a variety of human malignancies. Nevertheless, definitive dosimetric data are yet unavailable. According to the Society of Nuclear Medicine and Molecular Imaging, researchers are investigating the safety and efficacy of this radiotracer to meet Food and Drug Administration requirements. The aim of this study was to introduce the optimized procedure for 68Ga-DOTATOC preparation, using a novel germanium-68 (68Ge)/68Ga generator in Iran and evaluate the absorbed doses in numerous organs with high accuracy. Methods: The optimized conditions for preparing the radiolabeled complex were determined via several experiments by changing the ligand concentration, pH, temperature and incubation time. Radiochemical purity of the complex was assessed, using high-performance liquid chromatography and instant thin-layer chromatography. The absorbed dose of human organs was evaluated, based on biodistribution studies on Syrian rats via Radiation Absorbed Dose Assessment Resource Method. Results: 68Ga-DOTATOC was prepared with radiochemical purity of >98% and specific activity of 39.6 MBq/nmol. The complex demonstrated great stability at room temperature and in human serum at 37°C at least two hours after preparation. Significant uptake was observed in somatostatin receptor-positive tissues such as pancreatic and adrenal tissues (12.83 %ID/g and 0.91 %ID/g, respectively). Dose estimations in human organs showed that the pancreas, kidneys and adrenal glands received the maximum absorbed doses (0.105, 0.074 and 0.010 mGy/MBq, respectively). Also, the effective absorbed dose was estimated at 0.026 mSv/MBq for 68Ga-DOTATOC. Conclusion: The obtained results showed that 68Ga-DOTATOC can be considered as an effective agent for clinical PET imaging in Iran.
first_indexed 2024-12-11T06:53:36Z
format Article
id doaj.art-b0657298ef334b34aa9b0aea249a763a
institution Directory Open Access Journal
issn 2322-5718
2322-5726
language English
last_indexed 2024-12-11T06:53:36Z
publishDate 2016-01-01
publisher Mashhad University of Medical Sciences
record_format Article
series Asia Oceania Journal of Nuclear Medicine and Biology
spelling doaj.art-b0657298ef334b34aa9b0aea249a763a2022-12-22T01:16:49ZengMashhad University of Medical SciencesAsia Oceania Journal of Nuclear Medicine and Biology2322-57182322-57262016-01-0141192910.7508/aojnmb.2016.04.0045043Preclinical Studies of 68Ga-DOTATOC: Biodistribution Assessment in Syrian Rats and Evaluation of Absorbed Dose in Human Organsmojdeh naderi0samaneh zolghadri1hassan yousefnia2ali ramazani3amir reza jalilian4Department of Chemistry, University of Zanjan, Zanjan, IranNuclear Science and Technology Research Institute (NSTRI), Tehran, IranNuclear Science and Technology Research Institute (NSTRI), Tehran, IranDepartment of Chemistry, University of Zanjan, Zanjan, IranNuclear Science and Technology Research Institute (NSTRI), Tehran, IranObjective(s): Gallium-68 DOTA-DPhe1-Tyr3-Octreotide (68Ga-DOTATOC) has been applied by several European centers for the treatment of a variety of human malignancies. Nevertheless, definitive dosimetric data are yet unavailable. According to the Society of Nuclear Medicine and Molecular Imaging, researchers are investigating the safety and efficacy of this radiotracer to meet Food and Drug Administration requirements. The aim of this study was to introduce the optimized procedure for 68Ga-DOTATOC preparation, using a novel germanium-68 (68Ge)/68Ga generator in Iran and evaluate the absorbed doses in numerous organs with high accuracy. Methods: The optimized conditions for preparing the radiolabeled complex were determined via several experiments by changing the ligand concentration, pH, temperature and incubation time. Radiochemical purity of the complex was assessed, using high-performance liquid chromatography and instant thin-layer chromatography. The absorbed dose of human organs was evaluated, based on biodistribution studies on Syrian rats via Radiation Absorbed Dose Assessment Resource Method. Results: 68Ga-DOTATOC was prepared with radiochemical purity of >98% and specific activity of 39.6 MBq/nmol. The complex demonstrated great stability at room temperature and in human serum at 37°C at least two hours after preparation. Significant uptake was observed in somatostatin receptor-positive tissues such as pancreatic and adrenal tissues (12.83 %ID/g and 0.91 %ID/g, respectively). Dose estimations in human organs showed that the pancreas, kidneys and adrenal glands received the maximum absorbed doses (0.105, 0.074 and 0.010 mGy/MBq, respectively). Also, the effective absorbed dose was estimated at 0.026 mSv/MBq for 68Ga-DOTATOC. Conclusion: The obtained results showed that 68Ga-DOTATOC can be considered as an effective agent for clinical PET imaging in Iran.http://aojnmb.mums.ac.ir/pdf_5043_76a2ad14878b96963330ff68c4e18f99.htmlGa-68OctreotideInternal DosimetrySomatostatin
spellingShingle mojdeh naderi
samaneh zolghadri
hassan yousefnia
ali ramazani
amir reza jalilian
Preclinical Studies of 68Ga-DOTATOC: Biodistribution Assessment in Syrian Rats and Evaluation of Absorbed Dose in Human Organs
Asia Oceania Journal of Nuclear Medicine and Biology
Ga-68
Octreotide
Internal Dosimetry
Somatostatin
title Preclinical Studies of 68Ga-DOTATOC: Biodistribution Assessment in Syrian Rats and Evaluation of Absorbed Dose in Human Organs
title_full Preclinical Studies of 68Ga-DOTATOC: Biodistribution Assessment in Syrian Rats and Evaluation of Absorbed Dose in Human Organs
title_fullStr Preclinical Studies of 68Ga-DOTATOC: Biodistribution Assessment in Syrian Rats and Evaluation of Absorbed Dose in Human Organs
title_full_unstemmed Preclinical Studies of 68Ga-DOTATOC: Biodistribution Assessment in Syrian Rats and Evaluation of Absorbed Dose in Human Organs
title_short Preclinical Studies of 68Ga-DOTATOC: Biodistribution Assessment in Syrian Rats and Evaluation of Absorbed Dose in Human Organs
title_sort preclinical studies of 68ga dotatoc biodistribution assessment in syrian rats and evaluation of absorbed dose in human organs
topic Ga-68
Octreotide
Internal Dosimetry
Somatostatin
url http://aojnmb.mums.ac.ir/pdf_5043_76a2ad14878b96963330ff68c4e18f99.html
work_keys_str_mv AT mojdehnaderi preclinicalstudiesof68gadotatocbiodistributionassessmentinsyrianratsandevaluationofabsorbeddoseinhumanorgans
AT samanehzolghadri preclinicalstudiesof68gadotatocbiodistributionassessmentinsyrianratsandevaluationofabsorbeddoseinhumanorgans
AT hassanyousefnia preclinicalstudiesof68gadotatocbiodistributionassessmentinsyrianratsandevaluationofabsorbeddoseinhumanorgans
AT aliramazani preclinicalstudiesof68gadotatocbiodistributionassessmentinsyrianratsandevaluationofabsorbeddoseinhumanorgans
AT amirrezajalilian preclinicalstudiesof68gadotatocbiodistributionassessmentinsyrianratsandevaluationofabsorbeddoseinhumanorgans